Dashboard Market News Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
F:PCJ

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
F:PCJ
Watchlist
Price: 4.87 EUR -1.06% Market Closed
Market Cap: €199.5m
Write Note Create Alert Ask AI

Wall St Price Targets

PCJ Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast PCJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCJ is 13.12 EUR with a low forecast of 10.7 EUR and a high forecast of 22.24 EUR.

PCJ Lowest Forecast
Wall Street Target
€10.7
120% Upside
PCJ Average Forecast
Wall Street Target
€13.12
169% Upside
PCJ Highest Forecast
Wall Street Target
€22.24
357% Upside
Lowest Forecast
Price Target
10.7 EUR
120% Upside
Average Forecast
Price Target
13.12 EUR
169% Upside
Highest Forecast
Price Target
22.24 EUR
357% Upside
Abeona Therapeutics Inc Competitors:
Price Targets

Revenue
Forecast

2% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
2% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 71%.

What are analyst estimates?

Gross Profit
Forecast

0% / Year
Past Growth
185% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
0% / Year
Past Growth
185% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 185%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is -24%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 18%.

What are analyst estimates?

Continue PCJ Research

Summary
PCJ intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCJ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCJ stock valuation using valuation multiples.
Wall St Estimates
PCJ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCJ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Abeona Therapeutics Inc listings:
NASDAQ • USD
ABEO
 LSE • USD
0H7R
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCJ's stock price target?
Price Target
13.12 EUR

According to Wall Street analysts, the average 1-year price target for PCJ is 13.12 EUR with a low forecast of 10.7 EUR and a high forecast of 22.24 EUR.

What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 71%.

What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
185%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 185%.

What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-24%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -24%.

What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
18%

The compound annual growth rate for Net Income over the next 8 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.